Kiwoom Securities stated on July 29 that although HYBE recorded its highest-ever performance thanks to the BTS world tour, the company's share price plunged, diagnosing the current moment as an "aggressive buying opportunity."


Su-jin Lim, a researcher at Kiwoom Securities, said in a report titled "BTS Tour Power Proven, Performance Expectations Upgraded" released on the same day, "The current sharp short-term share price drop is excessive relative to the fundamentals," and maintained a "Buy" rating for HYBE with a target price of 330,000 won.

[Click eStock] "HYBE Plunges 16% Despite Record Earnings, Now Is the Time to Buy" View original image

The previous day, HYBE released its second quarter consolidated results, reporting sales of 1.45 trillion won and operating profit of 170.9 billion won. These figures represent increases of 105.5% and 159.4% year-on-year, respectively—far exceeding market consensus. The company’s earnings surprise is attributed to the BTS world tour’s huge success and higher average ticket price (ATP) across all artists.


However, the share price fell significantly immediately after the announcement. On the previous trading day, HYBE's share price closed at 188,800 won, down 16.09% from the previous session. Lim explained, "This is a typical sell-on-the-news pattern, driven by the negative macroeconomic environment due to a stock market crash and the fact that, contrary to the market's expectations for high-margin MD-led results, the performance segment with higher cost ratios led the top-line growth, resulting in upward earnings revision that fell short of short-term expectations."


Regarding HYBE’s second quarter gross profit margin (GPM) dropping to 32% from 43% in the previous quarter, she analyzed that this was due to a structural change in mix, with a significant increase in the proportion of concert sales, which have a relatively high royalties rate for artists. Lim further stated, "Concerns about temporarily lower concert margins have been overly reflected in the share price," and diagnosed, "While the apparent GPM fell due to the sharp rise in high-artist-settlement concert sales, profitability will become even more robust via MD demand in the second half of the year."


Accordingly, the company's operating profit estimate for the second half was analyzed to be upwardly adjustable by 20 billion won, with the 2027 estimate also raised by 50 billion won. Lim said, "The current share price has fallen to the 2027 forecast PER of 20 times, securing sufficient downside rigidity in valuation," and concluded, "Since 2027, the global tours of localized, relatively younger IPs such as Cortis and Cat’s Eye will begin in earnest, making the current moment an aggressive buying opportunity."



On the same day, Hana Securities also maintained its "Buy" rating on HYBE with a target price of 350,000 won. Kihoon Lee, a researcher at Hana Securities, said, "BTS’s world tour, which is expected to continue for at least through next year’s second quarter, will drive solid performance. Over the next year, comeback promotions from NewJeans and the eight-member Seventeen, as well as strong growth from Cortis and Cat’s Eye, are expected to continue." Lee added, "Despite the earnings surprise, the current PER for 2027 is just 20 times—even lower than during the panic selloff after BTS’s sudden military enlistment announcement (22 times)." He concluded, "Even given the market's current difficulties, the price is simply too attractive not to recommend, so we maintain both our overweight position and top pick."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing